Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Advanced Life Sciences to Explore Strategic Alternatives to Maximize Shareholder Value

January 3, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Jan. 3, 2011 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that...

Complaints and Concerns about Medicare Competitive Bidding for Home Medical Equipment Can Be Reported Via a Toll-Free Number and Website

December 31, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Dec. 31, 2010 /PRNewswire-USNewswire/ -- On January 1, 2011, Medicare starts a new "competitive bidding" program for durable medical equipment and supplies in nine metropolitan regions: Charlotte, Cincinnati, Cleveland, Dallas-Fort Worth, Kansas City, Miami, Orlando,...

New test announced for major killer of lung transplant patients

December 30, 2010 5:33 am | by EurekAlert | News | Comments

(University of Michigan Health System) A lung transplant can mean a new chance at life. But many who receive one develop a debilitating, fatal condition that causes scar tissue to build up in the lungs and chokes off the ability to breathe.University of Michigan researchers hope a new...

Advertisement

Uncovering the neurobiological basis of general anesthesia

December 29, 2010 1:33 pm | by EurekAlert | News | Comments

(Massachusetts General Hospital) A review article in the Dec. 30 New England Journal of Medicine brings together for the first time information from a range of disciplines, including neuroscience and sleep medicine, to lay the groundwork for more comprehensive investigations of processes...

ASU technology to treat chronic respiratory diseases

December 28, 2010 8:34 am | by Arizona State University | News | Comments

Miniature sensor technology developed at ASU's Biodesign Institute will be used to develop medical devices to better treat chronic respiratory diseases such as asthma.read more

Masimo to Present at 29th Annual J.P. Morgan Healthcare Conference

December 23, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Dec. 23, 2010 /PRNewswire / -- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday, January 11, 2011, at 11:30 a.m. PT.  A...

Generational Equity Announces Sale of B-Pharm, Inc. dba Remedies Pharmacy to a Private Investment Group

December 21, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

DALLAS, Dec. 21, 2010 /- Generational Equity, a leading advisor to privately held and family-owned businesses for mergers, acquisitions, strategic growth initiatives, business valuation and exit planning announced the acquisition of its client, B-Pharm, Inc. dba Remedies Pharmacy,...

Finnish researchers find a compound that prevents the growth of prostate cancer cells

December 20, 2010 6:32 am | by EurekAlert | News | Comments

(VTT Technical Research Centre of Finland) Researchers from VTT Technical Research Centre of Finland and the University of Turku have demonstrated that an antibiotic called "monensin" prevents the growth of prostate cancer cells. Monensin is used in the meat and dairy industry, for example.

Advertisement

CareFusion Launches EnVe Ventilator, Weighing 10 Times Less Than Traditional Critical Care Ventilators

December 20, 2010 6:31 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 20, 2010 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today launched the EnVe™ ventilator , a high-performance critical care ventilator that weighs 9.5 pounds—about 70-80 pounds lighter than other ventilators with similar functions....

Call for speakers to present at IQPC's MEDCon, the Medical Electronic Device Conference and Expo

December 17, 2010 5:36 am | by MEDCon | News | Comments

The Medical Electronic Device Conference & Expo (MEDCon), being held May 16 - 18, 2011 at Navy Pier in Chicago focuses on specific needs of electrical and design engineers for medical devices.

Beetroot juice could help people live more active lives

December 17, 2010 5:31 am | by EurekAlert | News | Comments

(University of Exeter) New research into the health benefits of beetroot juice suggests it's not only athletes who can benefit from its performance enhancing properties -- its physiological effects could help the elderly or people with heart or lung-conditions enjoy more active lives.

The high price of sleep disorders

December 17, 2010 5:30 am | by EurekAlert | News | Comments

(University of Copenhagen) Danish sleep researchers at the University of Copenhagen and the Danish Institute for Health Services Research have examined the socio-economic consequences of the sleep disorder hypersomnia in one of the largest studies of its kind. The sleep disorder has...

Beaumont Hospital Launches Study of Single-Dose Radiation Treatment for Prostate Cancer

December 16, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

ROYAL OAK, Mich., Dec. 16, 2010 /- Beaumont Hospital radiation oncologists have launched a research study to treat men with low to intermediate risk prostate cancer with a single dose of radiation. Alvaro Martinez, M.D., FACR, professor and chair, Oakland University William Beaumont...

Advertisement

ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors

December 16, 2010 6:31 am | by RealWire | News | Comments

PHILADELPHIA, PA, 16 December 2010 ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions. As the ePRO market...

NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial

December 16, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Dec. 16, 2010 /- Novavax, Inc. (Nasdaq: NVAX ) announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no...

New research finds delaying surgical procedures increases infection risk and health care costs

December 15, 2010 1:31 pm | by EurekAlert | News | Comments

(Weber Shandwick Worldwide) Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the...

Novel therapy for metastatic kidney cancer developed at VCU Massey Cancer Center

December 15, 2010 7:32 am | by EurekAlert | News | Comments

(Virginia Commonwealth University) Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the...

Amira Pharmaceuticals Announces the Nomination of an Orally Available Pre-Clinical Candidate in a New LPA-Related Program, an Autotaxin Inhibitor

December 15, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 15, 2010 /- Amira Pharmaceuticals, Inc. announced today that it has successfully identified a novel pre-clinical candidate for its newest lysophosphatidic acid (LPA)-related program, autotaxin.  Autotaxin is an enzyme upstream from LPA receptors and has been...

SMD Platinum RTD Temperature Sensor Suited for Biomedical Applications

December 15, 2010 5:45 am | Heraeus Sensor Technology USA | Product Releases | Comments

Heraeus Sensor Technology has introduced a surface mount platinum RTD temperature sensing element uniquely suited for use in biomedical applications.

Accuray Receives FDA Clearance for the CyberKnife® System's Lung Optimized Treatment

December 15, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Dec. 15, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market Lung Optimized Treatment, a new component of the...

New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment

December 13, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Dec. 13, 2010 /- Masimo (Nasdaq: MASI ) announced today that a new clinical study demonstrating the accuracy of its latest medical technology breakthrough— Rainbow Acoustic Monitoring™ —was presented last week at the American Association of Respiratory...

Apartment-dwelling children in nonsmoking units still exposed

December 12, 2010 10:31 pm | by EurekAlert | News | Comments

(University of Rochester Medical Center) Children living in apartments are exposed to secondhand smoke even when no one smokes inside their own unit. This study, released online today by the journal Pediatrics, strongly suggests that housing type contributes to children's exposure to...

High CTC Levels Predicted Poor Outcome in Metastatic Breast Cancer

December 10, 2010 9:31 am | by AACR | News | Comments

SAN ANTONIO - A high level of circulating tumor cells (CTCs) - cells that have detached from a tumor and are circulating in the body through the blood - are an independent prognostic marker in metastatic breast cancer as first-line therapy. In addition, persistence of high CTC level...

Mylan Receives Approval for Generic Version of Adalat® CC Tablets

December 10, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Dec. 10, 2010 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-release Tablets USP,...

Tomophase OCTIS(TM) Receives FDA 510(K) Clearance to Market

December 10, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 10, 2010 /- Tomophase Corporation, developer of the non-invasive Optical Coherence Tomography Imaging System (OCTIS™) and other devices, announced today that it has received FDA 510(k) clearance to market OCTIS. Tomophase is a leader in the development of OCT...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading